LOS ANGELES — The Los Angeles Dodgers’ quest for baseball immortality came to a screeching, painful halt in October, but the true toll of their postseason collapse is only now becoming clear.
Fresh off a crushing elimination in the National League Championship Series, two-way megastar Shohei Ohtani revealed that he faces a daunting road back to health, acknowledging that multiple surgical procedures may be necessary this winter to address a mounting list of physical ailments.
The admission transformed an already bitter playoff exit into an existential crisis for the franchise. Bargaining with time, anatomy, and the physical limits of modern athletic performance, Ohtani spent the final weeks of the season fighting through severe knee inflammation and biceps discomfort. Now, as the Dodgers clean out their lockers long before the World Series, baseball’s greatest global icon must once again surrender to the surgeon’s scalpel.
Shohei Ohtani in the Dodgers dugout during high-stakes October baseball.
Playing Through the Pain: Inside Ohtani’s October Struggle
The Dodgers entered October carrying the formidable weight of high expectations. Yet behind closed doors, their $700 million cornerstone was competing on borrowed time.
Speculation surrounding Ohtani’s physical condition reached a fever pitch during the NLCS, where his signature explosive swing seemed noticeably muted. The designated hitter managed just four hits in 22 postseason at-bats, failing to record a single extra-base hit while chasing pitches well outside his customary danger zone.
Internal discussions within the Dodgers organization even turned toward benching the superstar or shifting him down the lineup to grant his body respite. Before Game 3, manager Dave Roberts slated Ohtani into the lower third of the batting order—the first time Ohtani batted that low since 2020. But Ohtani fiercely rebuffed any suggestions of taking a seat.
“No star player voluntarily steps out of a game this critical,” Roberts admitted to reporters, detailing how Ohtani insisted he was healthy enough to contribute.
Despite his publicly maintaining that his mechanical slump was unrelated to his physical ailments, Ohtani admitted following the team’s elimination that medical consultations regarding both his knee and biceps were looming. When asked directly if operating procedures would be required before Spring Training, Ohtani admitted it was “hard to tell” until comprehensive medical imaging and evaluations were completed in the coming days.
Ohtani addressing the media after the Dodgers’ heartbreaking postseason exit.
Anatomy of a Superhuman Burden
| Injury / Medical Focus Area | Affected Region | Potential Offseason Impact |
| Biceps Tendon Discomfort | Upper Arm / Throwing Mechanism | Could delay dynamic throwing programs and mound progression. |
| Patellar / Knee Inflammation | Lower Body / Power Generation | May limit rotational hip drive, lower-half mechanics, and running speed. |
| Ulnar Collateral Ligament (Historical Context) | Elbow / Pitching Arm | Requires cautious management following previous major reconstructions. |
The potential necessity of dual operations underscores the immense, unprecedented physical strain placed on a player who routinely defies baseball logic.
Unlike conventional major leaguers who specialize in either hitting or pitching, Ohtani’s daily regimen demands maximum kinetic energy transfer across every joint and muscle group. Generating elite exit velocities at the plate places heavy torque on the lead knee and upper torso; simultaneously, delivering triple-digit heat from the mound puts tremendous stress on the elbow and shoulder complex.
When one link in that biological chain falters, the entire mechanism suffers. League scouts noted that as Ohtani’s knee issues escalated in late September, his hip rotation at the plate stalled, forcing his upper body and arms to overcompensate. That overcompensation may have accelerated the irritation in his upper arm and biceps.
Can the Two-Way Model Endure Long-Term?
The looming surgical procedures reignite a critical question that has hovered over Major League Baseball since Ohtani first arrived from Japan: How long can the human body sustain elite elite two-way production?
Ohtani’s ambition remains steadfast. Even while fielding questions about potential surgeries, he reiterated his firm intent to return to the mound next season as a full two-way threat.
“My goal is always to be out there pitching and hitting,” Ohtani maintained. “That hasn’t changed.”
Ohtani aiming for a full return to his dual-threat role next season.
However, front offices across Major League Baseball are watching closely. The Dodgers made an unprecedented financial commitment to Ohtani, betting that his unique talents would yield multiple championship banners. But with every surgical intervention, the risk profile shifts.
Sports medicine specialists point out that recovery from multiple lower-body and upper-body procedures simultaneously is extraordinarily grueling. Rebuilding strength in a landing leg while rehabilitating a throwing arm requires precise timing, preventing an athlete from over-training one side to make up for the other.
High Stakes in Hollywood
For the Dodgers, the stakes could not be higher. The franchise built its roster architecture around Ohtani’s presence as a generational multi-hyphenate star.
If Ohtani is forced into extensive offseason rehabilitation, his availability for Opening Day—either as a designated hitter or as an elite starting pitcher—could be compromised. A delayed timeline would throw Los Angeles’ pitch-rotation planning into flux and place immense pressure on an already taxed bullpen.
Furthermore, the emotional fallout of their abrupt postseason elimination looms over Chavez Ravine. After dominating the regular season, watching their crown jewel hobble through October served as a sobering reminder that talent alone cannot override biology.
As Ohtani prepares to meet with team doctors and orthopedic specialists to finalize his surgical roadmap, the baseball world holds its breath. The Dodgers’ offseason has arrived earlier than planned—and its success will be measured not in free-agent signings, but in successful operations and long-term healing.
